Significant improvement in operating performance – Revenue up 69%; Adjusted EBITDA up 76% Planned consolidation of cannabis operations under MariMed banner advancing on schedule The launch of MariMed Hemp operations including the development of CBD brands and products   Conversion of debt investment... read more →